U.S. Clinical Trial: Fox Chase Cancer Center Listed a New Clinical Trial to Study Enfortumab Vedotin Schedule De-escalation in Metastatic Urothelial Carcinoma

Press/Media

PeriodJun 28 2023

Media coverage

1

Media coverage